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Hepatitis C virus (HCV) infects an
estimated 3% of humanity [1] and is a
leading global cause of liver disease and
liver cancer [2]. Intervention is currently
limited by the lack of a vaccine and of
universally successful drug treatments.
Although several next-generation drugs
(e.g., direct-acting protease-inhibitors) are
already improving outcomes, a number of
factors will affect overall treatment success
[3]. Among these, viral genetic variation
and the emergence of drug resistance are
of major importance.
It is now recognized that effective pre-
vention and treatment of HCV infection
requires an appreciation of the virus’
evolutionary behaviour. HCV evolves very
rapidly during infection within a host,
resulting in a genetically diverse viral
population (often termed a ‘‘quasispecies’’)
whose composition is determined by a
combination of evolutionary processes that
include mutation, replication rate, natural
selection, and random genetic drift. As a
consequence, patterns of HCV genetic
diversity within infected patients (if correctly
analysed) should reveal information about
the evolutionary dynamics of infection and
could uncover links between viral evolution
and the progression of clinical disease.
Studies that have followed this logic are
too numerous to review here and vary
widely in the number and health status of
patients investigated, the timespan over
which viruses are sampled, and the quality
of viral genetic information obtained
(ranging from whole viral genomes to
heteroduplex mobility assay data). In most
studies, HCV genomic sequences are
obtained from peripheral blood and are
summarized using two measures: the
diversity of sequences sampled at any one
time and the divergence among sequences
sampled at different times. No clear-cut
patterns in these statistics among patients
with HCV have emerged. For example,
with respect to patient outcomes, high
diversity in the HCV envelope region is
associated with progression from acute to
chronic infection [4,5] yet also with milder
symptoms [6,7] and possibly with poorer
outcomes after drug treatment [8].
It is helpful to interpret these results in
the context of evolutionary theory. First, it
is well-established that much of the evolu-
tionary information inherent in sequence
data is lost when they are compressed into
summary statistics such as diversity or
divergence [9,10]. In retrospect, it is
perhaps optimistic to expect one or two
numerical values to capture much of the
complexity of host–viralinteractions during
infection. Second, and more importantly,
theory tells us that an evolutionary model is
always required to infer the behaviour of a
viral population from sequences sampled
from it [11,12]. When previous HCV
studies have correlated diversity with pa-
tient outcomes, they have, by default,
implicitly applied a very simple evolution-
ary model—one that assumes a single, well-
mixed viral population whose members all
replicate and evolve identically.
However, phylogenetic analyses of with-
in-patient HCV sequences indicate that
this simple model is insufficient to explain
HCV evolutionary dynamics during infec-
tion. Specifically, phylogenies reconstruct-
ed from HCV genomes sampled from
multiple time points frequently reveal two
or more genetically distinct co-existing
viral lineages that are not detected at all
sampling times; this is seen in both acute
[13] and chronic (e.g., [14–17]) infection.
Figure 1a presents an illustrative within-
patient phylogeny, in which lineages 3 and
4 co-exist for more than 10 years.
Crucially, the composition of viruses
sampled from peripheral blood varies
greatly; at one time point only lineage 3
is detected, whilst at the next only lineage
4 might be seen; at yet other times both
lineages are observed. The phylogeny thus
explains why simple measures of sample
diversity oscillate wildly (Figure 1b). By
applying more sophisticated methods (see
figure legend and [11]), it becomes
possible to estimate the genetic diversity
of the whole viral population, which is
comparatively constant through time
(Figure 1c). We therefore suggest that the
diversity scores (Figure 1b) commonly used
in HCV studies do not fully represent the
dynamics of infection.
The behaviour illustrated in Figure 1
requires a more complex model than is
commonly assumed. We believe the most
important feature missing from current
descriptions of HCV dynamics is population
structure; without this, it is very difficult to
explain why viral lineages that remain
unobserved for several years do not go
extinct before later reappearing (Figure 1).
Consequently, we propose a new evolu-
tionary model for HCV, in which the
lineages that co-exist during chronic
infection represent genetically distinct
subpopulations of infected liver cells
(Figure 1d; extra-hepatic replication is
discussed below). Importantly, this model
can reconcile many aspects of HCV
within-host genetic data (i.e., the data in
Figure 1a–1c).
The observation that only a subset of
viral subpopulations is detected in serum
at any given time may be explained by one
of two modulating mechanisms. First, all
viral lineages present in the liver may be
shed at a roughly constant rate, but levels
of neutralizing antibodies targeting specific
epitopes may fluctuate over time, modify-
ing the relative frequency of those lineages
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subpopulations may replicate or shed virus
at different rates. Factors that might
generate such variation include the effect
of host cell type on viral replication
dynamics, interaction with interferons, or
viral interference in the cell cycle [18].
The presence of replication rate variation
is supported by mathematical models of
HCV infection kinetics [19] and may help
explain why HCV quasispecies exhibit
strong heterogeneity in the rate of molec-
ular evolution [20].
The notion of HCV population struc-
ture is consistent with a wide variety of
experimental data, including evidence for
cell-to-cell viral transmission [21,22], the
observation of hepatic foci of infection
[23], and HCV genetic variation within
the liver [24]. Although our illustration
(Figure 1d) represents viral sub-popula-
tions existing in different liver locations,
the population structure we propose could
equally arise from non-hepatic replication,
as detected in monocytes/macrophages
[25], lymphocytes [26], and brain tissue
[27]. These cells often harbor viruses with
distinct genetic signatures [28,29].
The under-appreciated complexity of
chronic HCV evolution has several prac-
tical consequences. First, simple statistics
of viral genetic variation (sample diversity,
divergence) will be of limited utility; we
instead recommend that analyses begin
with a phylogenetic approach. Second,
our model suggests that viruses sampled
from peripheral blood give an incomplete
picture of HCV infection dynamics.
Where possible, future studies should
incorporate additional sites, including liver
biopsies, explant livers, and other cell
types. Third, population structure can
maintain high viral diversity within a
patient even when serum viraemia and
diversity are low, perhaps contributing to
the evolution of drug resistance and to
treatment failure. The emergence of new
anti-HCV drugs therefore makes the
understanding of HCV evolutionary dy-
namics a research priority.
References
1. WHO (2010) HCV: surveillance and control.
Available: http://www.who.int/csr/disease/
hepatitis/whocdscsrlyo2003/en/index4.html. Ac-
cessed 6 April 2012.
2. CDC (2010) Hepatocellular carcinoma - United
States, 2001–2006. MMWR Morb Mortal Wkly
Rep 59: 517–552.
3. Kuntzen T, Timm J, Berical A, Lennon N,
Berlin AM, et al. (2008) Naturally occurring
dominant resistance mutations to hepatitis C
virus protease and polymerase inhibitors in
treatment-naı ¨ve patients. Hepatology 48:
1769–1778.
4. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G,
et al. (2000) The outcome of acute hepatitis C
predicted by the evolution of the viral quasispe-
cies. Science 288: 339–344.
5. Thomson EC, Fleming VM, Main J,
Klenerman P, Weber J, et al. (2011) Predicting
spontaneous clearance of acute hepatitis C virus
in a large cohort of HIV-1-infected men. Gut 60:
837–845.
6. Sullivan D, Bruden D, Deubner H, McArdle S,
Chung M, et al. (2007) Hepatitis C virus
dynamics during natural infection are associated
with long-term histological outcome of chronic
hepatitis C disease. J Infect Dis 196: 239–248.
7. Farci P, Quinti I, Farci S, Alter HJ, Strazzera R,
et al. (2006) Evolution of hepatitis C viral
quasispecies and hepatic injury in perinatally
infected children followed prospectively. Proc
Natl Acad Sci U S A 103: 8475–8480.
8. Morishima C, Polyak SJ, Ray R, Doherty MC,
Di Bisceglie AM, et al. (2006) Hepatitis C virus-
specific immune responses and quasi-species
variability at baseline are associated with nonre-
sponse to antiviral therapy during advanced
hepatitis C. J Infect Dis 193: 931–940.
9. Felsenstein J (1992) Estimating effective popula-
tion size from samples of sequences: inefficiency
of pairwise and segregating sites as compared to
phylogenetic estimates. Genet Res 59: 139–147.
10. Steel MA, Hendy MD, Penny D (1988) Loss of
information in genetic distances. Nature 336: 118.
11. Lemey P, Rambaut A, Pybus OG (2006) HIV
evolutionary dynamics within and among hosts.
AIDS Rev 8: 125–140.
12. Wilson DJ, Falush D, McVean G (2005) Germs,
genomes and genealogies. Trends Ecol Evol 20:
39–45.
13. Smith JA, Aberle JH, Fleming VM, Ferenci P,
Thomson EC, et al. (2010) Dynamic coinfection
with multiple viral subtypes in acute hepatitis C.
J Infect Dis 202: 1770–1779.
14. Alfonso V, Mbayed VA, Sookoian S, Campos RH
(2005) Intra-host evolutionary dynamics of hep-
atitis C virus E2 in treated patients. J Gen Virol
86: 2781–2786.
15. Li H, McMahon BJ, McArdle S, Bruden D,
Sullivan DG, et al. (2008) Hepatitis C virus
envelope glycoprotein co-evolutionary dynamics
during chronic hepatitis C. Virology 375: 580–591.
16. Wang X, Netski DM, Astemborski J, Mehta SH,
Torbenson MS, Thomas DL, et al. (2007)
Progression of fibrosis during chronic hepatitis
C is associated with rapid virus evolution. J Virol
81: 6513–6522.
17. Ramachandran S, Campo DS, Dimitrova ZE,
Xia GL, Purdy MA, et al. (2011) Temporal
variations in the hepatitis C virus intrahost
population during chronic infection. J Virol 85:
6369–6380.
18. Kannan RP, Hensley LL, Evers LE, Lemon SM,
McGivern DR, et al. (2011) Hepatitis C virus
infection causes cell cycle arrest at the level of
initiation of mitosis. J Virol 85: 7989–8001.
19. Neumann AU, Lam NP, Dahari H, Gretch DR,
Wiley TE, et al. (1998) Hepatitis C viral dynamics
in vivo and the antiviral efficacy of interferon-
alpha therapy. Science 282: 103–107.
2 0 .G r a yR R ,P a r k e rJ ,L e m e yP ,S a l e m iM ,
Katzourakis A, et al. (2011) The mode and
tempo of hepatitis C virus evolution within and
among hosts. BMC Evol Biol 11: 131.
21. Liang Y, Shilagard T, Xiao SY, Snyder N, Lau D,
et al. (2009) Visualizing hepatitis C virus
infections in human liver by two-photon micros-
copy. Gastroenterology 137: 1448–1458.
22. Brimacombe CL, Grove J, Meredith LW, Hu K,
Syder AJ, et al. (2011) Neutralizing antibody-
resistant hepatitis C virus cell-to-cell transmission.
J Virol 85: 596–605.
23. Stiffler JD, Nguyen M, Sohn JA, Liu C,
Kaplan D, et al. (2009) Focal distribution of
hepatitis C virus RNA in infected livers. PLoS
ONE 4: e6661.
24. Sobesky R, Feray C, Rimlinger F, Derian N, Dos
Santos A, et al. (2007) Distinct hepatitis C virus
core and F protein quasispecies in tumoral and
nontumoral hepatocytes isolated via microdissec-
tion. Hepatology 46: 1704–1712.
25. Laskus T, Radkowski M, Piasek A, Nowicki M,
Horban A, et al. (2000) Hepatitis C virus in
lymphoid cells of patients coinfected with human
immunodeficiency virus type 1: evidence of active
replication in monocytes/macrophages and lym-
phocytes. J Infect Dis 181: 442–448.
26. Laskus T, Operskalski EA, Radkowski M,
Wilkinson J, Mack WJ, et al. (2007) Negative-
strand hepatitis C virus (HCV) RNA in peripheral
blood mononuclear cells from anti-HCV-positive/
HIV-infected women. J Infect Dis 195: 124–133.
27. Radkowski M, Wilkinson J, Nowicki M, Adair D,
Vargas H, et al. (2002) Search for hepatitis C virus
negative-strand RNA sequences and analysis of
viral sequences in the central nervous system:
evidence of replication. J Virol 76: 600–608.
28. Ducoulombier D, Roque-Alfonso AM, Di
Liberto G, Penin F, Kara R, et al. (2004)
Frequent compartmentalization of hepatitis C
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(E1E2 region) sampled longitudinally from a single infected individual (Pt11 in [7]). Sequences were obtained from serum at twelve occasions over 15
years. All results are placed on the same time scale (top). (a) The phylogeny of the sampled sequences was reconstructed using a molecular clock
model, such that branch lengths represent time (calculated using BEAST v1.6.2 [30]). To aid explanation, branches have been grouped into four
lineages, indicated by colour. Lineages 3 and 4 co-exist between months 30 and 145. Lineage 4 was present in the patient but undetected at months
65, 116, 132, 145. (b) The average diversity of sequences obtained at each sampling time (mean pairwise genetic distance; calculated using MEGA v4
[31]). The vertical scale represents mean substitutions per site. Sample diversity is notably higher at month 82 because both lineages 3 and 4 are
detected. (c) An estimate of the genetic diversity of the whole viral quasispecies through time. This figure was calculated using the Bayesian skyline
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around the estimate (solid line). (d) A new evolutionary model of HCV infection, as applied to the patient data shown in (a), (b), and (c). Each cartoon
represents the state of infection at a different time, as indicated by the shaded areas. Circles represent different sub-populations of HCV-infected cells
within the liver (or other sites of extra-hepatic replication), coloured to correspond to the lineages in (a). Solid arrows indicate the fluctuating
detection of HCV lineages in serum through time.
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